Document Detail


Initiating a Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes Mellitus.
MedLine Citation:
PMID:  22267299     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Control of blood glucose levels and restoration of pancreatic islet function are among the goals of physicians seeking to improve outcomes in patients with type 2 diabetes mellitus (T2DM). A growing body of evidence supports the use of incretins to achieve these goals, and current guidelines recommend earlier and more frequent use of these agents. However, in patients with T2DM, treatment paradigms should always be individualized. The author discusses issues for physicians to consider when adjusting T2DM therapy, including patient comorbidities, glucose control patterns, and potential adverse effects. The importance of patient education and practical points for initiating a glucagon-like peptide-1 receptor agonist are also reviewed.
Authors:
James R Gavin
Related Documents :
6439589 - Impaired growth hormone response to human pancreatic growth hormone releasing factor [g...
3286449 - Comparison of the acute metabolic effects of 22,000-dalton and 20,000-dalton growth hor...
15063799 - Monocyte chemoattractant protein 1 expression is stimulated by growth hormone and inter...
18094069 - Maternal protein restriction leads to early life alterations in the expression of key m...
1516889 - The effect of the somatostatin analogue octreotide on growth hormone secretion in insul...
10229529 - Mechanical modulation of calf tail vertebral growth: implications for scoliosis progres...
14742839 - Insulin action on expression of novel adipose genes in healthy and type 2 diabetic subj...
8172089 - Thiamin deficiency impairs endotoxin-induced increases in hepatic glucose output.
1222999 - Acid inhibiton in insulin test- a preliminary report.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of the American Osteopathic Association     Volume:  112     ISSN:  1945-1997     ISO Abbreviation:  J Am Osteopath Assoc     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-01-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7503065     Medline TA:  J Am Osteopath Assoc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S16-21     Citation Subset:  IM    
Affiliation:
145 Bayberry Run, Fayetteville, GA 30214-2671. jrgavin3@yahoo.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-system...
Next Document:  Improving Glucagon-like Peptide-1 Dynamics in Patients With Type 2 Diabetes Mellitus.